Avalon GloboCare Announces Completion of Clinical-Grade Exosome Bio-Production Standardization with Launch of “ACTEX” Product Commercialization Jun 10, 2019
Avalon GloboCare to produce its first series of clinical-grade exosome products by end of 2019 Jun 7, 2019 Life Science
CStone received approval to initiate clinical development in China of CS1001 and BLU-554 (CS3008) in combination therapy for HCC Jun 5, 2019 Life Science
Frontage Holdings Corporation Celebrates a Successful Initial Public Offering on the HKEx Jun 4, 2019 Life Science
Jiangsu Provincial Institute of Materia Medica Selects Provantis Preclinical SaaS Solution Jun 4, 2019 Life Science
Medical Marijuana, Inc. Announces International Coverage at FDA Public Hearing on Cannabis and CBD Products Jun 3, 2019 Cannabis, Life Science
AstraZeneca and Merck to Seek Regulatory Approval for Lynparza in Pancreatic Cancer Jun 3, 2019 Life Science
CStone submits new drug application for TIBSOVO(R) in Taiwan for the treatment of relapsed/refractory AML Jun 3, 2019 Life Science
